ORAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2021-04-19 1465389cm38暂无昵称

偏重的研究方向：头颈肿瘤
经验分享：Apr 18 变化一次时间

62 0

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2021-03-30 1465389cm38暂无昵称

Mar 28 Under Review

57 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2019-12-24 sci2008

请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表:
感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。

139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。

171 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2020-01-10 146academ18暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。

228 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2020-05-04 ms9430612511402566

审稿速度:1.0
经验分享：1 礼拜编辑直接拒绝。

156 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2020-04-19 丫丫3036

978372

145 0

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2019-12-03 1470cd80m57暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。

144 0

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2019-01-09 Dr_Hemis_AI

做头颈肿瘤分期的风信子苗 2018-12-20 发表::
您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表:
您好，做的什么研究

风信子苗 2018-12-20 发表:: 您好，做的什么研究

218 0

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2018-12-20 风信子苗

您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表:
投了一篇， 1個月整有回覆 Revise

Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise

235 0

[GetPortalCommentsPageByObjectIdResponse(id=958391, encodeId=0533958391f2, content=偏重的研究方向：头颈肿瘤 经验分享：Apr 18 变化一次时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Mon Apr 19 16:00:04 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952382, encodeId=23df95238220, content=Mar 28 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Tue Mar 30 15:19:48 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582110, encodeId=8b1b582110c2, content=请问case收吗139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=139****2557暂无昵称 2019-12-03 00:00:00 发表: 感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d4a1632093, createdName=sci2008, createdTime=Tue Dec 24 00:00:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583031, encodeId=9ac0583031a1, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：7月投稿，三个月后回复，reject。但是审稿意见很没说服力，所以写信去申诉。申诉后杂志同意给个机会。再次送审。2个月后，还是reject。审稿意见依旧无法说出拒稿理由。明明是很新颖的文章，写得也很好，但是还是没中。能不能中就看你遇到好的rrviews不。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0805157601, createdName=146academ18暂无昵称, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860179, encodeId=951a8601e94e, content=审稿速度:1.0 经验分享：1 礼拜编辑直接拒绝。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 04 19:10:34 CST 2020, time=2020-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589264, encodeId=db71589264ed, content=978372, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0TdaQ5tZNia6oNwdbFjibhjiaW5oZgetas4tOn8DILl2k7rvt91cng4fLgvyAlia80bT08libv5ZQpbw/132, createdBy=b5795317557, createdName=丫丫3036, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580856, encodeId=4d53580856b3, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：感谢梅斯医学经验交流平台，刚接收一篇，很兴奋，小分类牙科与口腔外科1区也算1区文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/10/7358bc8a906f27cbe72110b117bfbc9a.jpg, createdBy=062d5187377, createdName=1470cd80m57暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565377, encodeId=2b2c5653e7b7, content=做头颈肿瘤分期的风信子苗 2018-12-20 发表:: 您好，做的什么研究风信子苗 2018-12-20 00:00:00 发表: 您好，做的什么研究, beContent=风信子苗 2018-12-20 发表:: 您好，做的什么研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Wed Jan 09 00:00:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564702, encodeId=3d92564e0214, content=您好，做的什么研究Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2582316822, createdName=风信子苗, createdTime=Thu Dec 20 00:00:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562799, encodeId=eef8562e99af, content=一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表: 投了一篇， 1個月整有回覆 Revise, beContent=Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 06 00:00:00 CST 2018, time=2018-11-06, status=1, ipAttribution=)]

2018-11-06 Dr_Hemis_AI

一個半月后修改提交。 6天后接受。 Dr_Hemis_AI 2018-09-10 发表::
接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 ReviseDr_Hemis_AI 2018-09-10 00:00:00 发表:
投了一篇， 1個月整有回覆 Revise

Dr_Hemis_AI 2018-09-10 发表:: 接收率：约50% 审稿时间：约2个月投了一篇， 1個月整有回覆 Revise

248 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务